Document is current
Any future updates will be listed below
-
Authors
Brioli, Annamaria https://orcid.org/0000-0002-4072-7592
vom Hofe, Felix
Rucci, Paola
Ernst, Thomas
Yomade, Olaposi
Hilgendorf, Inken https://orcid.org/0000-0003-2038-9730
Scholl, Sebastian
Sayer, Herbert
Mügge, Lars-Olof
Hochhaus, Andreas
von Lilienfeld-Toal, Marie
- License Information
-
More Information
Article History
Received: 19 July 2020
Revised: 9 November 2020
Accepted: 20 November 2020
First Online: 9 December 2020
Compliance with ethical standards
:
: AB received honoraria and travel grants from Celgene, Takeda, Gilead, and Janssen, honoraria from Sanofi, GSK, and Amgen and research support from Celgene; LOM received honoraria and travel grants from Bristol-Myers Squibb, Celgene, Janssen, Novartis, Takeda and research support from Celgene; AH received research support from Novartis, Bristol-Myers Squibb, Pfizer, and Incyte; IH received travel grants from Celgene, GILEAD, Jazz Pharma, Sanofi and honoraria from Novartis and Jazz Pharma; MvLT has received honoraria and travel grants and from Celgene, Gilead, Chugai, Janssen, Novartis, Amgen, Takeda, BMS, Medac, Oncopeptides, Merck, CDDF, Pfizer, is a consultant for Celgene, Gilead, Oncopeptides, MSD, 4DPharma, Janssen, Shionogi and received research funding from BMBF, Deutsche Jose Carreras Leukämie-Stiftung, IZKF Jena, Novartis, Gilead, Deutsche Krebshilfe, Celgene, Deutsche Forschungsgemeinschaft; the other authors have no conflict of interest to report.
